VR Logo

Vanta Bioscience Ltd. download report


Chemicals | Misc.Chem.

Vanta Bioscience Ltd. Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 Vanta Bioscience Ltd. Annual Report Vanta Bioscience Ltd. director's report Vanta Bioscience Ltd. management discussion Vanta Bioscience Ltd. auditor's report Vanta Bioscience Ltd. account notes
2020 Vanta Bioscience Ltd. Annual Report Vanta Bioscience Ltd. chairman speech Vanta Bioscience Ltd. director's report Vanta Bioscience Ltd. management discussion Vanta Bioscience Ltd. corporate governance Vanta Bioscience Ltd. auditor's report Vanta Bioscience Ltd. account notes
2019 Vanta Bioscience Ltd. Annual Report Vanta Bioscience Ltd. chairman speech Vanta Bioscience Ltd. director's report Vanta Bioscience Ltd. management discussion Vanta Bioscience Ltd. corporate governance Vanta Bioscience Ltd. auditor's report Vanta Bioscience Ltd. account notes
2018 Vanta Bioscience Ltd. Annual Report Vanta Bioscience Ltd. chairman speech Vanta Bioscience Ltd. director's report Vanta Bioscience Ltd. management discussion Vanta Bioscience Ltd. corporate governance Vanta Bioscience Ltd. auditor's report Vanta Bioscience Ltd. account notes
2017 Vanta Bioscience Ltd. Annual Report Vanta Bioscience Ltd. chairman speech Vanta Bioscience Ltd. director's report Vanta Bioscience Ltd. management discussion Vanta Bioscience Ltd. corporate governance Vanta Bioscience Ltd. auditor's report Vanta Bioscience Ltd. account notes

About The Company

Business: Research and experimental development on natural sciences and engineering

Incorporated: 2016

Chairman: Mohan Krishna Mulakala

Managing Director: Dopesh Raja Mulakala

Listing: BSE: 540729

Country: India

Headquarters: Hyderabad, Telangana

Website: www.vantabio.com

Key Facts

Market cap: ₹62.30 Cr

Revenue (TTM): ₹9.82 Cr

Earnings (TTM): ₹0.45 Cr

Cash: ₹2.65 Cr

Total Debt: ₹35.97 Cr

Promoters' ownership: 69.00%

Liquidity: Low

52 Week range: ₹82.25 - 189.00

Face value: ₹10.00

Shares outstanding: 63,12,000

5 Years Aggregate:

  • CFO: ₹1.26 Cr
  • EBITDA: ₹12.62 Cr
  • Net Profit: ₹2.19 Cr

Stock Performance

Time Period Vanta Bioscience S&P BSE Basic Materials* S&P BSE Small Cap*
YTD-22.13-18.39-15.86
1 month-4.64-8.49-3.26
3 months-29.20-21.97-10.93
1 Year-33.76-12.93-1.22
3 Years-14.7816.4020.29
5 Years--9.5410.12
10 Years----14.25
As on 21-Jun-2022 *As on 30-Jun-2022
Year Vanta Bioscience S&P BSE Small Cap S&P BSE Basic Materials
2021-3.2462.7761.53
202017.2332.1126.07
201933.49-6.85-4.62
201828.26-23.41-19.21